earnings call
In Q4 Amwell reported $60.4 million in revenue up 34% from Q4 2019.
The telehealth brand's annual revenue increased 80% YoY to $148.8 million in 2020, although its quarterly YoY growth dipped in Q4 compared to the months prior.
The virtual care company disclosed all-time-high revenue and membership growth during 2020, yet offered 2021 projections below what investors anticipated.
The company attributes volume growth, new patient additions and increasing awareness of real-time continuous glucose monitoring to its revenue growth.
Dexcom President and CEO Kevin Sayer is “incredibly proud” of what the company is calling “resilient growth” in the second quarter of 2020, according to an earnings call on Tuesday.
Although the company's rapid growth has been fueled by COVID-19, new contracts and state-by-state trends have CEO Jason Gorevic confident that telehealth adoption is here to stay.
While the company saw a 25% increase in revenue year-over-year it failed to meet earnings per share expectations.
Also Fitbit struggles as it waits to be acquired by Google, and Livongo sees strong growth.
Although it's still operating in the red, the digital chronic disease management company logged 149% revenue growth in 2019.
During its latest earnings call, the remote care company highlighted its new offerings for enterprise customers and discussed how it's been preparing for an increase in infectious disease cases.